AtaiBeckley ATAI
US equityBiotechnology
$0.00 +$0.00 (0.00%)
Market closed · Nov 20, 9:30 am ET
Open$0.00
Prev close$0.00
Day range$0.00 – $0.00
Volume0.00
Market cap–
P/E (TTM)–
Dividend yield–
ATAI Stock News
Headlines matching AtaiBeckley or the ATAI ticker, most recent first.
- News On AtaiBeckley Inc. (ATAI) Now Under LLY
- AtaiBeckley: AtaiBeckley Inc. - Cash Settlement/Acceleration of Expirations Option Symbol: ATAI
- H.C. Wainwright Maintains AtaiBeckley(ATAI.US) With Hold Rating, Maintains Target Price $7.5
- Analysts' Opinions Are Mixed on These Healthcare Stocks: Atai Beckley N.V. (ATAI), InspireMD (NSPR) and Silexion Therapeutics (SLXN)
- Oppenheimer Downgrades AtaiBeckley(ATAI.US) to Hold Rating Negative
- Deutsche Bank Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $8 Negative
- AtaiBeckley: AtaiBeckley Inc. - Anticipated Cash Settlement Option Symbol: ATAI
- Analysts Offer Insights on Healthcare Companies: Genmab (GMAB), Definitive Healthcare Corp (DH) and Atai Beckley N.V. (ATAI)
- H.C. Wainwright Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $7.5 Negative
- Berenberg Bank Downgrades AtaiBeckley(ATAI.US) to Hold Rating, Cuts Target Price to $7.45 Negative
- Berenberg Bank Sticks to Their Buy Rating for Atai Beckley N.V. (ATAI)
- Maxim Group Maintains AtaiBeckley(ATAI.US) With Hold Rating
- Berenberg Bank Maintains AtaiBeckley(ATAI.US) With Buy Rating, Maintains Target Price $14
- TD Cowen Downgrades AtaiBeckley(ATAI.US) to Hold Rating Negative
- A Quick Look at Today's Ratings for AtaiBeckley(ATAI.US), With a Forecast Between $7.5 to $8
No comments yet — be the first to weigh in on ATAI.
Sign in to join the discussion.